Annexon ANNX
NASDAQ ANNX
$4.84 -0.01 (-0.10%)
As of: Sep 4, 2026 · 1:38 PM EDT

Annexon (ANNX) Change in Accured Expenses (2019 - 2026)

Annexon (ANNX) posted quarterly Change in Accured Expenses of -$9.4 million for Q1 2026, down 421.22% year-over-year from $2.9 million in Q1 2025, and down 517.73% quarter-over-quarter from $2.2 million in Q4 2025.

Analysis

Annexon (ANNX) Change in Accured Expenses (2019 - 2026) Analysis & Trends

Annexon's Change in Accured Expenses history runs 8 years deep, the most recent figure standing at -$9.4 million for Q1 2026.

  • In Q1 2026, Change in Accured Expenses fell 421.22% year-over-year to -$9.4 million; the TTM figure through Mar 2026 stood at -$5.1 million (down 137.55% YoY), while the FY2025 annual figure was $7.2 million, down 0.95% from the prior year.
  • Change in Accured Expenses for Q1 2026 stood at -$9.4 million, down from $2.2 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $6.7 million in Q4 2024, with the low at -$9.4 million in Q1 2026.
  • The 5-year median for Change in Accured Expenses is $10000.0 (2022), against an average of $92941.2.
  • Peak annual rise in Change in Accured Expenses reached 25350.0% in 2023, while the deepest fall reached 6796.0% in 2023.
  • Annexon's Change in Accured Expenses stood at $10000.0 in 2022, then plunged by 6190.0% to -$609000.0 in 2023, then soared by 1201.31% to $6.7 million in 2024, then tumbled by 66.45% to $2.2 million in 2025, then plunged by 517.73% to -$9.4 million in 2026.
  • Business Quant data shows ANNX's Change in Accured Expenses at -$9.4 million in Q1 2026, $2.2 million in Q4 2025, and -$3.9 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn 222.50 Mn
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn 492.70 Mn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn -
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn 11.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn - 55.78 Mn
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn 212.44 Mn
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn 61.62 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn - -
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn 68.82 Mn
10 Annexon 970.85 Mn 970.85 Mn - 4.23 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.23 Mn
Mar 31, 2026 -9.40 Mn
Dec 31, 2025 2.25 Mn
Sep 30, 2025 -3.87 Mn
Jun 30, 2025 5.92 Mn
Mar 31, 2025 2.93 Mn
Dec 31, 2024 6.71 Mn
Sep 30, 2024 412,000.00
Jun 30, 2024 3.54 Mn
Mar 31, 2024 -3.37 Mn
Dec 31, 2023 -609,000.00
Sep 30, 2023 1.53 Mn
Jun 30, 2023 -1.72 Mn
Mar 31, 2023 -2.77 Mn
Dec 31, 2022 2.14 Mn
Sep 30, 2022 3.31 Mn
Jun 30, 2022 2.60 Mn
Mar 31, 2022 -1.86 Mn
Dec 31, 2021 592,000.00
Sep 30, 2021 828,000.00